We obtain, expand, trigger and maintain differentiation of cells on a large scale compatible with clinical conditions. Multiple questions will arise from considering the clinical potential of the MSCs and will be solved by working together with clinicians and people involved in safety and regulatory administrations.

 

This workblock is managed by J T Vilquin working with:

 

 

 

 

 P Charbord                                       T Haupl                                       N Neves                                               Y Chernajovsky

(Uni Tours-France)                           (Charite-Germany)                  (Uni Minho-Portugal)                                 (QMUL-UK)

 

 

 

 

 

           

 

       

 

 

        P Bianco                                          G Gross                                         P Marie                                            JP Mouscadet

  (Uni Roma-Italy)                                   (HZI-Germany)                            (Inserm-France)                               (Abcys-France)

 

 

 

 

 

 

 

 

 

     H Papadaki                                          C Jorgensen                                      E Livne

  (Uni Crete-Greece)                               (Inserm-France)                              (Technion-Israel)

Work block 7: Transition to the clinic